Efficacy Study of TACE to Treat Hepatocellular Carcinoma After Operation

NCT02631499 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Hepatocellular
Neoplastic Cells, Circulating

Interventions

PROCEDURE: TACE
DRUG: Epirubicin
DRUG: lipiodol

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]